Exagamglogene autotemcel
Generic name: exagamglogene autotemcel
Brand name: Casgevy
Dosage form: intravenous suspension (-)
Drug class: Miscellaneous uncategorized agents
What is exagamglogene autotemcel?
Exagamglogene autotemcel is used to treat sickle cell disease in adults and children at least 12 years old who have frequent vaso-occlusive crises (pain due to clogged small blood vessels).
Exagamglogene autotemcel may also be used for purposes not listed in this medication guide.
Exagamglogene autotemcel side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Tell your medical caregivers right away if you have:
-
chills, fever, infections;
-
severe headache;
-
unusual bruising or bleeding; or
-
nosebleeds, bleeding gums, blood in your urine or vomit, bloody or tarry stools, or coughing up blood.
Common side effects of exagamglogene autotemcel may include:
-
fever, mouth sores, skin sores, sore throat, cough; or
-
easy bruising, unusual bleeding, purple or red spots under your skin.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Related/similar drugs
Zynteglo
Zynteglo (betibeglogene autotemcel) is a gene therapy indicated for the treatment of patients with ...
Casgevy
Casgevy (exagamglogene autotemcel) is a gene therapy that is given as a one-time intravenous ...
Reblozyl
Reblozyl is used to treat anemia (low red blood cells) in certain patients with beta-thalassemia or ...
Oxbryta
Oxbryta (voxelotor) is used for the treatment of patients with sickle cell disease (SCD). Oxbryta ...
Lyfgenia
Lyfgenia (lovotibeglogene autotemcel) is a gene therapy that uses a viral vector and is given as a ...
Lovotibeglogene autotemcel
Lovotibeglogene autotemcel systemic is used for sickle cell disease
Luspatercept
Luspatercept (brand name Reblozyl) is used to treat anemia (low red blood cells) in certain ...
Warnings
Tell your doctor if you use other medicines or have other medical conditions or allergies.
You may get infections or bleed more easily. Call your doctor if you have severe headache, unusual bleeding or signs of infection (fever, cough, skin sores, painful urination).
Before taking this medicine
Tell your doctor if you have or have ever had:
-
hepatitis, HIV or AIDS;
-
stem cell transplant; or
-
liver or kidney disease.
Tell your doctor if you recently received a vaccine or are scheduled to receive a vaccine.
Exagamglogene autotemcel may affect fertility in men or women. Pregnancy could be harder to achieve while either parent is using exagamglogene autotemcel. Talk to your doctor about options for fertility preservation, like sperm banking or egg preservation.
Exagamglogene autotemcel can harm an unborn baby if the mother or the father is using this medicine.
-
If you are a woman, you may need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 6 months after your last dose.
-
If you are a man, use birth control if your sex partner is able to get pregnant. Keep using birth control for at least 6 months after your last dose.
-
Tell your doctor right away if a pregnancy occurs.
Do not breastfeed while using this medicine. Ask a doctor if it is safe to breastfeed after using this medicine.
How is exagamglogene autotemcel given?
Follow all directions on your prescription label and read all medication guides or instruction sheets.
Exagamglogene autotemcel is part of a treatment plan used after a procedure called apheresis, where cells from the blood are removed for stem cell transplant.
Exagamglogene autotemcel is injected into a vein by a healthcare provider.
You may need to stay in the hospital for 4 to 6 weeks after your treatment with exagamglogene autotemcel. Talk with your doctor if you have any questions.
You may be given other medications before your treatment.
Your blood will be tested before and after treatment with exagamglogene autotemcel.
What happens if I miss a dose?
In a medical setting you are not likely to miss a dose.
What happens if I overdose?
In a medical setting an overdose would be treated quickly.
What should I avoid while receiving exagamglogene autotemcel?
Do not donate blood, organs, tissues, or cells for transplantation after receiving exagamglogene autotemcel.
What other drugs will affect exagamglogene autotemcel?
Tell your doctor about all your other medicines, especially:
-
disease modifying drugs such as: hydroxyurea, crizanlizumab, voxelotor, and others; or
-
iron chelating agents such as: deferasirox, deferiprone, and deferoxamine.
This list is not complete. Other drugs may affect exagamglogene autotemcel, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Exagamglogene autotemcel Biosimilars
Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product.
Reference products
These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There is 1 for exagamglogene autotemcel.
Casgevy (Exagamglogene autotemcel) - Vertex Pharmaceuticals Inc
Formulation type | Strength |
---|---|
Single-Dose Vial | 4-13 × 10^6 CELL/mL |
View Casgevy information in detail.
More about exagamglogene autotemcel
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous uncategorized agents
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Cerner Multum, Inc. Version: 1.01.